TCTAP A-063 Medium-term Clinical Outcomes of the Everolimus-eluting Bioresorbable Vascular Scaffold in Real-world Practice

TCTAP A-063 Medium-term Clinical Outcomes of the Everolimus-eluting Bioresorbable Vascular Scaffold in Real-world Practice

In this study, we aim to assess the safety and medium-term clinical outcomes of BVS in percutaneous coronary intervention (PCI) of real-world patients presenting with both stable coronary artery disease and acute coronary syndrome in a tertiary institution. Patients were stratified into ST-segment e...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of the American College of Cardiology 2017-04, Vol.69 (16), p.S33-S34
Hauptverfasser: Kajiya, Takashi, Mao-Chen Liang, Michael, Ng, Perryn, Chi-Hang Lee, Ronald, Chan, Mark, Lik-Wui Tay, Edgar, Chan, Koo Hui, Loh, Joshua P, Loh, Poay-Huan, Tan, Huay Cheem, Low, Adrian
Format: Artikel
Sprache:eng
Schlagworte:
Acute coronary syndromes
Angina pectoris
Biocompatibility
Biomedical materials
Cardiology
Cardiovascular
Cardiovascular disease
Clinical outcomes
Coronary artery
Coronary artery disease
Coronary vessels
Electrocardiography
Heart attacks
Heart diseases
Inhibitor drugs
Internal Medicine
Intervention
Myocardial infarction
Patients
Surgical implants
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:In this study, we aim to assess the safety and medium-term clinical outcomes of BVS in percutaneous coronary intervention (PCI) of real-world patients presenting with both stable coronary artery disease and acute coronary syndrome in a tertiary institution. Patients were stratified into ST-segment elevation myocardial infarction (STEMI), non-ST-segment elevation acute...
ISSN:0735-1097
1558-3597
DOI:10.1016/j.jacc.2017.03.092